Development of Hemostatic Agents

Abstract

To assess the efficacy of a series of novel hemostatic agents in normal and coagulopathic animals subjected to femoral artery hemorrhage. The hemostatic agents comprise different carrier matrices for the delivery of the lead compound CP-305. The objective set forth in this research was to identify candidate formulations that could ultimately prevent hypovolemia and exsanguination resulting from traumatic battlefield injuries.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2005
Accession Number
ADA454187

Entities

People

  • Bob M. Moore Ii

Organizations

  • University of Tennessee

Tags

DTIC Thesaurus Topics

  • Arteries
  • Battlefields
  • Blood
  • Blood Coagulation
  • Collagen
  • Combat Injuries
  • Dosage Forms
  • Health Care
  • Health Services
  • Hemorrhage
  • Hemostasis
  • Hypovolemia
  • Lead Compounds
  • Materials
  • Patent Applications
  • Pilot Studies

Fields of Study

  • Medicine

Readers

  • Trauma Surgery or Emergency Medicine.